tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders StocksMarket MoversTipRanks 50 IndexDividend StocksAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Research Tools
Trending StocksCompare StocksCompare ETFsTrump Dashboard
New
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Trending News
More News >
Education
Personal FinanceHow To Use TipRanksTipRanks LabsWebinar CenterGlossaryFAQs
About Us
About TipRanksContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News Wire
Follow Us
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders Stocks
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Trump Dashboard
New
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA

OLMA Stock Latest News

Olema Pharmaceuticals Holds Annual Stockholders Meeting
Company AnnouncementsOlema Pharmaceuticals Holds Annual Stockholders Meeting
15d ago
8K
OLMA
Promising Clinical Trial Results Justify Buy Rating for Olema Pharmaceuticals
PremiumRatings
Promising Clinical Trial Results Justify Buy Rating for Olema Pharmaceuticals
27d ago
OLMA
Olema Pharmaceuticals: Strategic Dose Selection and Financial Projections Support Positive Outlook
PremiumRatings
Olema Pharmaceuticals: Strategic Dose Selection and Financial Projections Support Positive Outlook
1M ago
OLMA
Olema Oncology announces palazestrant dose selection, trial-in-progress poster
PremiumThe Fly
Olema Oncology announces palazestrant dose selection, trial-in-progress poster
1M ago
OLMA
Olema Oncology Advances Cancer Trials with Strong Financials
PremiumCompany Announcements
Olema Oncology Advances Cancer Trials with Strong Financials
1M ago
OLMA
Olema Oncology price target lowered to $22 from $25 at Oppenheimer
PremiumThe FlyOlema Oncology price target lowered to $22 from $25 at Oppenheimer
2M ago
OLMA
Olema Pharmaceuticals: Promising Pipeline and Strategic Trials Support Buy Rating
Premium
Ratings
Olema Pharmaceuticals: Promising Pipeline and Strategic Trials Support Buy Rating
2M ago
OLMA
Olema Pharmaceuticals: Promising Clinical Trials and Strategic Advancements Drive Buy Rating
Premium
Ratings
Olema Pharmaceuticals: Promising Clinical Trials and Strategic Advancements Drive Buy Rating
2M ago
OLMA
Olema Oncology reports Q1 EPS (36c), consensus (46c)
PremiumThe Fly
Olema Oncology reports Q1 EPS (36c), consensus (46c)
2M ago
OLMA
OLMA Upcoming Earnings Report: What to Expect?
PremiumPre-Earnings
OLMA Upcoming Earnings Report: What to Expect?
2M ago
OLMA
Oncology stocks ‘bearing the brunt’ of Prasad news, says Oppenheimer
PremiumThe Fly
Oncology stocks ‘bearing the brunt’ of Prasad news, says Oppenheimer
2M ago
IDYA
NRIX
Promising Outlook for Olema Pharmaceuticals: Buy Rating Affirmed Amid Strategic Positioning in ER+ Breast Cancer Treatment
PremiumRatings
Promising Outlook for Olema Pharmaceuticals: Buy Rating Affirmed Amid Strategic Positioning in ER+ Breast Cancer Treatment
3M ago
OLMA
Olema Oncology price target lowered to $28 from $30 at JPMorgan
PremiumThe FlyOlema Oncology price target lowered to $28 from $30 at JPMorgan
3M ago
OLMA
Positive Outlook on Olema Pharmaceuticals Driven by Promising Phase II Trial Results and Upcoming Phase III Initiation
Premium
Ratings
Positive Outlook on Olema Pharmaceuticals Driven by Promising Phase II Trial Results and Upcoming Phase III Initiation
3M ago
OLMA
Olema Oncology Reports 2024 Financial and Clinical Progress
Premium
Company Announcements
Olema Oncology Reports 2024 Financial and Clinical Progress
3M ago
OLMA
Promising Clinical Data and Market Opportunities Drive Buy Rating for Olema Pharmaceuticals
PremiumRatings
Promising Clinical Data and Market Opportunities Drive Buy Rating for Olema Pharmaceuticals
3M ago
OLMA
Olema Oncology price target lowered to $25 from $30 at Oppenheimer
PremiumThe Fly
Olema Oncology price target lowered to $25 from $30 at Oppenheimer
3M ago
OLMA
Olema Oncology reports Q4 EPS (51c), consensus (63c)
PremiumThe Fly
Olema Oncology reports Q4 EPS (51c), consensus (63c)
3M ago
OLMA
Oppenheimer biotech analyst holds an analyst/industry conference call
PremiumThe Fly
Oppenheimer biotech analyst holds an analyst/industry conference call
3M ago
AZN
LLY
Promising Efficacy of Olema Pharmaceuticals’ Palazestrant Supports Buy Rating
PremiumRatingsPromising Efficacy of Olema Pharmaceuticals’ Palazestrant Supports Buy Rating
4M ago
OLMA
Olema Pharmaceuticals: Promising Clinical Results and Strong Financial Health Support Buy Rating
Premium
Ratings
Olema Pharmaceuticals: Promising Clinical Results and Strong Financial Health Support Buy Rating
4M ago
OLMA
Olema updated palazestrant combination trial, says Oppenheimer
Premium
The Fly
Olema updated palazestrant combination trial, says Oppenheimer
4M ago
OLMA

Trending

Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >